{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:45:10Z","timestamp":1787244310574,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004242","name":"Princess Nourah bint Abdulrahman University","doi-asserted-by":"publisher","award":["PNURSP2025R814"],"award-info":[{"award-number":["PNURSP2025R814"]}],"id":[{"id":"10.13039\/501100004242","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.urolonc.2025.08.009","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T08:14:33Z","timestamp":1758701673000},"page":"711.e9-711.e27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Deciphering the role of zingiber officinale phytochemicals for the treatment of prostate cancer: Interactions of phytochemicals with androgen receptor prostate cancer mutant H874Y ligand binding domain"],"prefix":"10.1016","volume":"43","author":[{"given":"Guanghui","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sireen Abdul Rahim","family":"Shilbayeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Vohra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahzad","family":"Rasheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salah-Ud-Din","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahanavaj","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2025.08.009_bib0001","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.phrs.2016.10.001","article-title":"Androgen receptor variation affects prostate cancer progression and drug resistance","volume":"114","author":"McCrea","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0002","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.3390\/cancers16213689","article-title":"Prognostic value of neutrophil-to-eosinophil ratio (NER) in cancer: a systematic review and meta-analysis","volume":"16","author":"Sahin","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0003","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3390\/cancers13030546","article-title":"Bone targeting agents in patients with metastatic prostate cancer: state of the art","volume":"13","author":"Mollica","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0004","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.semcancer.2021.09.007","article-title":"Microbiota and prostate cancer","volume":"86","author":"Rizzo","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0005","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/10408363.2024.2322565","article-title":"Implication of calcium supplementations in health and diseases with special focus on colorectal cancer","volume":"61","author":"Khan","year":"2024","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0006","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.clnesp.2025.03.023","article-title":"Prognostic significance of the cachexia index (CXI) in patients with cancer: a systematic review and meta-analysis","volume":"68","author":"Bas","year":"2025","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189229","article-title":"Implication of Toll-Like Receptors in growth and management of health and diseases: special focus as a promising druggable target to Prostate Cancer","volume":"1880","author":"Khan","year":"2025","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0008","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1210\/me.2005-0231","article-title":"Mutation of histidine 874 in the androgen receptor ligand-binding domain leads to promiscuous ligand activation and altered p160 coactivator interactions","volume":"19","author":"Duff","year":"2005","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0009","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/aja.2010.89","article-title":"Androgen receptor signaling and mutations in prostate cancer","volume":"12","author":"Koochekpour","year":"2010","journal-title":"Asian J Androl"},{"issue":"Suppl 1","key":"10.1016\/j.urolonc.2025.08.009_bib0010","first-page":"S25","article-title":"Androgen receptor genomic alterations and treatment resistance in metastatic prostate cancer","volume":"82","author":"Kwan","year":"2022","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0011","doi-asserted-by":"crossref","first-page":"25801","DOI":"10.1074\/jbc.M703268200","article-title":"Modulation of androgen receptor activation function 2 by testosterone and dihydrotestosterone","volume":"282","author":"Askew","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0012","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.4161\/cc.6.11.4353","article-title":"The complex role of AR signaling after cytotoxic insult: implications for cell-cycle-based chemotherapeutics","volume":"6","author":"Comstock","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0013","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1038\/onc.2013.206","article-title":"Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches","volume":"32","author":"Karantanos","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0014","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.mce.2011.08.007","article-title":"Androgen receptor coregulators: recruitment via the coactivator binding groove","volume":"352","author":"van de Wijngaart","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0015","doi-asserted-by":"crossref","first-page":"26029","DOI":"10.18632\/oncotarget.4347","article-title":"Development and exploitation of a novel mutant androgen receptor modelling strategy to identify new targets for advanced prostate cancer therapy","volume":"6","author":"O'Neill","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1137783","article-title":"Urolithin A analog inhibits castration-resistant prostate cancer by targeting the androgen receptor and its variant, androgen receptor-variant 7","volume":"14","author":"Chandrasekaran","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0017","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/aps.2014.18","article-title":"Androgen receptor: structure, role in prostate cancer and drug discovery","volume":"36","author":"Tan","year":"2015","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0018","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/pros.20191","article-title":"Androgen receptor mutants detected in recurrent prostate cancer exhibit diverse functional characteristics","volume":"63","author":"Chen","year":"2005","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0019","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc4016","article-title":"Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer","volume":"15","author":"Watson","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0020","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.euo.2024.11.005","article-title":"Apalutamide in metastatic castration-sensitive prostate cancer: results from the multicenter real-world ARON-3 study","volume":"8","author":"Santoni","year":"2025","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032514","article-title":"The impact of point mutations in the human androgen receptor: classification of mutations on the basis of transcriptional activity","volume":"7","author":"Hay","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0022","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1517\/14656566.2015.1055249","article-title":"Androgen pathway resistance in prostate cancer and therapeutic implications","volume":"16","author":"Maughan","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0023","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/foods8060185","article-title":"Bioactive compounds and bioactivities of ginger (Zingiber officinale Roscoe)","volume":"8","author":"Mao","year":"2019","journal-title":"Foods"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0024","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1158\/1940-6207.CAPR-13-0055","article-title":"Ginger: is it ready for prime time?","volume":"6","author":"Stoner","year":"2013","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0025","article-title":"[6]-gingerol inhibits chikungunya virus infection by suppressing viral replication","volume":"27","author":"Hayati","year":"2021","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.117733","article-title":"Pharmacodynamic components and mechanisms of ginger (Zingiber officinale) in the prevention and treatment of colorectal cancer","volume":"324","author":"Xiang","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0027","doi-asserted-by":"crossref","first-page":"e5993","DOI":"10.1002\/bmc.5993","article-title":"Assessment of the anticancer potential of certain phenolic and flavonoid components in ginger capsules using colorectal cancer cell lines coupled with quantitative analysis","volume":"38","author":"Al Azzam","year":"2024","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0028","doi-asserted-by":"crossref","first-page":"6599","DOI":"10.3390\/ijms22126599","article-title":"Mechanisms of chemopreventive and therapeutic proprieties of ginger extracts in cancer","volume":"22","author":"Zadorozhna","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0029","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1758-2946-4-17","article-title":"Avogadro: an advanced semantic chemical editor, visualization, and analysis platform","volume":"4","author":"Hanwell","year":"2012","journal-title":"J Cheminform"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0031","unstructured":"Discovery Studio Visualizer Software, Version 21.1.0.20298. 2021. BIOVIA, Dassault Syst\u00e8mes. https:\/\/www.3ds.com\/products-services\/biovia\/products\/molecular-modeling-simulation\/biovia-discovery-studio."},{"key":"10.1016\/j.urolonc.2025.08.009_bib0032","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"key":"10.1016\/j.urolonc.2025.08.009_bib50","doi-asserted-by":"crossref","first-page":"W345","DOI":"10.1093\/nar\/gkz424","article-title":"PrankWeb: a web server for ligand binding site prediction and visualization","volume":"47","author":"Jendele","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0033","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/ct700301q","article-title":"GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation","volume":"4","author":"Hess","year":"2008","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0034","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/1756-0500-5-367","article-title":"ACPYPE: antechamber python parser interface","volume":"5","author":"Sousa da Silva","year":"2012","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0035","doi-asserted-by":"crossref","first-page":"20593","DOI":"10.1039\/C7CP02557B","article-title":"Developing force fields when experimental data is sparse: AMBER\/GAFF-compatible parameters for inorganic and alkyl oxoanions","volume":"19","author":"Kashefolgheta","year":"2017","journal-title":"Phys Chem Chem Phys"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0036","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","article-title":"Automatic atom type and bond type perception in molecular mechanical calculations","volume":"25","author":"Wang","year":"2006","journal-title":"J Mol Graph Model"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0037","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/prot.22711","article-title":"Improved side-chain torsion potentials for the Amber ff99SB protein force field","volume":"78","author":"Lindorff-Larsen","year":"2010","journal-title":"Proteins"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0038","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1021\/jp003020w","article-title":"Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K","volume":"105","author":"Mark","year":"2001","journal-title":"J Phys Chem A"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0039","doi-asserted-by":"crossref","first-page":"11901","DOI":"10.1080\/07391102.2023.2265492","article-title":"An exploration of binding of Hesperidin, Rutin, and Thymoquinone to acetylcholinesterase enzyme using multi-level computational approaches","volume":"42","author":"Mir","year":"2024","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0040","doi-asserted-by":"crossref","DOI":"10.1002\/jcb.30515","article-title":"Nonsynonymous mutations in VEGF receptor binding domain alter the efficacy of bevacizumab treatment","volume":"125","author":"Ahamed","year":"2024","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.sjbs.2022.103478","article-title":"Structural insights into conformational stability and binding of thiazolo-[2,3-b] quinazolinone derivatives with EGFR-TKD and in-vitro study","volume":"29","author":"Ahmad Mir","year":"2022","journal-title":"Saudi J Biol Sci"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0042","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12900-017-0077-9","article-title":"A computational assessment of pH-dependent differential interaction of T7 lysozyme with T7 RNA polymerase","volume":"17","author":"Borkotoky","year":"2017","journal-title":"BMC Struct Biol"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0043","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: a linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J Computat Chem"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0044","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1007\/s11030-023-10688-6","article-title":"Bioinspired thiazolo-[2,3-b] quinazolin-6-one derivatives as potent anti-cancer agents targeting EGFR: their biological evaluations and in silico assessment","volume":"28","author":"Mir","year":"2024","journal-title":"Mol Divers"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0045","doi-asserted-by":"crossref","first-page":"016002","DOI":"10.1088\/1478-3975\/ad0caa","article-title":"An exploration of the binding prediction of anatoxin-a and atropine to acetylcholinesterase enzyme using multi-level computer simulations","volume":"21","author":"Mir","year":"2023","journal-title":"Phys Biol"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0046","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J Mol Graph"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0047","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"g_mmpbsa\u2013a GROMACS tool for high-throughput MM-PBSA calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0048","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s00894-020-04383-8","article-title":"Effects of oligolignol sizes and binding modes on a GH11 xylanase inhibition revealed by molecular modeling techniques","volume":"26","author":"Muhammad","year":"2020","journal-title":"J Mol Model"},{"key":"10.1016\/j.urolonc.2025.08.009_bib0049","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1002\/prot.23018","article-title":"Virtual screening using molecular simulations","volume":"79","author":"Yang","year":"2011","journal-title":"Proteins"},{"key":"10.1016\/j.urolonc.2025.08.009_bib51","article-title":"Effect of ginger extracts on colorectal cancer HCT-116 cell line in the expression of MMP-2 and KRAS","volume":"21","author":"Malmir","year":"2020","journal-title":"Gene Rep"},{"key":"10.1016\/j.urolonc.2025.08.009_bib52","first-page":"001","article-title":"Ginger extract (Zingiber officinale) triggers apoptosis and G0\/G1 cells arrest in HCT 116 and HT 29 colon cancer cell lines","volume":"12","author":"Abdullah","year":"2018","journal-title":"Adv J Microbio Res"},{"key":"10.1016\/j.urolonc.2025.08.009_bib53","first-page":"1051","article-title":"Inhibitory Effects of Culinary Herbs and Spices on the Growth of HCA-7 Colorectal Cancer Cells and Their COX-2 Expression","volume":"9","author":"Jaksevicius","year":"2017"}],"updated-by":[{"DOI":"10.1016\/j.urolonc.2026.111003","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000}},{"DOI":"10.1016\/j.urolonc.2026.111003","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000}}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814392500314X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814392500314X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T20:02:59Z","timestamp":1780862579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107814392500314X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":53,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S107814392500314X"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.08.009","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deciphering the role of zingiber officinale phytochemicals for the treatment of prostate cancer: Interactions of phytochemicals with androgen receptor prostate cancer mutant H874Y ligand binding domain","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}